Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Lower Genit Tract Dis. 2013;17:S1–27.

Article  Google Scholar 

Hillemanns P, Soergel P, Hertel H, Jentschke M. Epidemiology and early detection of cervical cancer. Oncol Res Treat. 2016;39(9):501–6.

Article  PubMed  Google Scholar 

Ittiamornlert P, Ruengkhachorn I. Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy. BMC Cancer. 2019;19(1):1–10.

Article  Google Scholar 

Jonska-Gmyrek J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, Fuksiewicz M, Kotowicz B. Pre-treatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients. Cancer Manage Res. 2018;10:6029.

Article  Google Scholar 

Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):1–16.

Article  Google Scholar 

Lee YY, et al. Pre-treatment neutrophil: lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res. 2012;32(4):1555–61.

PubMed  Google Scholar 

Nakamura K, et al. Pre-treatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy. Mol Clin Oncol. 2015;3(5):1001–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Jiang W, Xi D, Chen J, Xu G, Yin W, Chen J, Gu W. Development and validation of a nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas. J Investig Med. 2019;67(3):691–8.

Article  PubMed  Google Scholar 

Geng Y, Zhu D, Wu C, Wu J, Wang Q, Li R, Jiang J, Wu C. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503–10.

Article  CAS  PubMed  Google Scholar 

Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, Liu L, Meng Z, Wang P, Chen Z. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158–67.

Article  PubMed  Google Scholar 

ICO (Information Centre on HPV and Cancer). (2017). Human Papilloma virus and related diseases report. Cyprus.

Lee JW, Seol KH. Pre-treatment Neutrophil-to-Lymphocyte ratio combined with Platelet-to-Lymphocyte ratio as a predictor of survival outcomes after definitive concurrent chemoradiotherapy for cervical cancer. J Clin Med. 2021;10(10):2199.

Article  PubMed  PubMed Central  Google Scholar 

Vano YA et al. (2018). Optimal cut-off for neutrophil-to-lymphocyte ratio: fact or fantasy? A prospective cohort study in metastatic cancer patients. PLoS ONE, 13(4), e0195042.

Liu C, Li X. Stage-Dependent changes in Albumin, NLR, PLR, and AFR are correlated with shorter survival in patients with gastric cancer. Clin Lab. 2019;65(9).

He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. Eur J Cancer Care. 2017;26(2):e12445.

Google Scholar 

Guo W, Lu X, Liu Q, Zhang T, Li P, Qiao W, Deng M. Prognostic value of neutrophil-to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: an updated meta‐analysis of 17079 individuals. Cancer Med. 2019;8(9):4135–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, Uchida E. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):646–54.

Article  PubMed  Google Scholar 

Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. OncoTargets Therapy. 2013;6:1605.

PubMed  PubMed Central  Google Scholar 

Abu-Shawer O, Abu-Shawer M, Hirmas N, Alhouri A, Massad A, Alsibai B, Al-Hussaini M. Hematologic markers of distant metastases and poor prognosis in gynaecological cancers. BMC Cancer. 2019;19(1):1–8.

Article  Google Scholar 

Zou P, Yang E, Li Z. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):1–10.

Article  CAS  Google Scholar 

Tóth Z, Lőczi L, Sebők B, Merkely P, Keszthelyi E, Lintner B, Ács N, Keszthelyi A, Várbíró S, Tóth R, Keszthelyi M. Neutrophil/Lymphocyte ratio (NLR) as a predictive marker for p16 positivity and cervical cancer progression: insights from the SCOPE study. Cancers (Basel). 2025;17(6):921. https://doi.org/10.3390/cancers17060921.

Article  CAS  PubMed  PubMed Central  Google Scholar